Pegylated thymalfasin
Alternative Names: Pegylated ZadaxinLatest Information Update: 02 Oct 2021
At a glance
- Originator Nektar Therapeutics; SciClone Pharmaceuticals
- Class Adjuvants; Anti-infectives; Antineoplastics; Antivirals; Oligopeptides; Thymus hormones
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Hepatitis B; Hepatitis C
Most Recent Events
- 02 Jun 2004 Preclinical trials in Cancer in USA (Parenteral)
- 02 Jun 2004 Preclinical trials in Hepatitis B in USA (Parenteral)
- 02 Jun 2004 Preclinical trials in Hepatitis C in USA (Parenteral)